214 related articles for article (PubMed ID: 17049832)
1. Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
Tang FY; Chiang EP; Shih CJ
J Nutr Biochem; 2007 Jun; 18(6):391-9. PubMed ID: 17049832
[TBL] [Abstract][Full Text] [Related]
2. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
Tang FY; Nguyen N; Meydani M
Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064
[TBL] [Abstract][Full Text] [Related]
3. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
[TBL] [Abstract][Full Text] [Related]
4. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M
Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757
[TBL] [Abstract][Full Text] [Related]
5. Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells.
Singh AK; Seth P; Anthony P; Husain MM; Madhavan S; Mukhtar H; Maheshwari RK
Arch Biochem Biophys; 2002 May; 401(1):29-37. PubMed ID: 12054484
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
[TBL] [Abstract][Full Text] [Related]
7. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
8. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs.
Piyaviriyakul S; Shimizu K; Asakawa T; Kan T; Siripong P; Oku N
Biol Pharm Bull; 2011; 34(3):396-400. PubMed ID: 21372391
[TBL] [Abstract][Full Text] [Related]
10. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
[TBL] [Abstract][Full Text] [Related]
11. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding.
Kondo T; Ohta T; Igura K; Hara Y; Kaji K
Cancer Lett; 2002 Jun; 180(2):139-44. PubMed ID: 12175544
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
[TBL] [Abstract][Full Text] [Related]
13. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB
Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556
[TBL] [Abstract][Full Text] [Related]
14. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer.
Wang J; Man GCW; Chan TH; Kwong J; Wang CC
Cancer Lett; 2018 Jan; 412():10-20. PubMed ID: 29024813
[TBL] [Abstract][Full Text] [Related]
15. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.
Sartippour MR; Shao ZM; Heber D; Beatty P; Zhang L; Liu C; Ellis L; Liu W; Go VL; Brooks MN
J Nutr; 2002 Aug; 132(8):2307-11. PubMed ID: 12163680
[TBL] [Abstract][Full Text] [Related]
16. Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase.
Guo BC; Wei J; Su KH; Chiang AN; Zhao JF; Chen HY; Shyue SK; Lee TS
Mol Nutr Food Res; 2015 Apr; 59(4):646-57. PubMed ID: 25581901
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
[TBL] [Abstract][Full Text] [Related]
18. Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate.
Annabi B; Lee YT; Martel C; Pilorget A; Bahary JP; Béliveau R
Cancer Biol Ther; 2003; 2(6):642-9. PubMed ID: 14688468
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
Chen CY; Lin YJ; Wang CCN; Lan YH; Lan SJ; Sheu MJ
Biomed Pharmacother; 2019 Dec; 120():109491. PubMed ID: 31586903
[TBL] [Abstract][Full Text] [Related]
20. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
